Issues in Infants with Prader-Will Syndrome: Special Review on Early Dietary Intervention and Early Use of Growth Hormone

키워드

참고문헌 (63)

1. Smith A, "Birth prevalence of Prader-Willi syndrome in Australia", Arch Dis Child, 88, pp.263~264 (2003)
2. Vogels A, "Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders", Eur J Hum Genet, 12, pp.238~240 (2004)
3. Cassidy SB, "Prader-Willi and Angelman syndromes: sister imprinted disorders", Am J Med Genet, 97, pp.136~146 (2000)
4. Eiholzer U, "Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome", Horm Res, 53(3), pp.44~52 (2000)
5. Burman P, "Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH", Endocr Rev, 22, pp.787~799 (2001)
6. Wollmann HA, "Reference values for height and weight in Prader- Willi syndrome based on 315 patients", Eur J Pediatr, 157, pp.634~642 (1998)
7. Glenn CC, "Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes", Mol Hum Reprod, 3, pp.321~332 (1997)
8. Glenn CC, "Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene", Am J Hum Genet, 58, pp.335~346 (1996)
9. Kubota T, "Methylation-specific PCR simplifies imprinting analysis", Nat Genet, 16, pp.16~17 (1997)
10. Trifiro G, "Neonatal hypotonia: don't forget the Prader-Willi syndrome", Acta Paediatr, 92, pp.1085~1089 (2003)
11. Bachere N, "Early diagnosis and multidisciplinary care reduce the hospitalization time and duration of tube feeding and prevent early obesity in PWS infants", Horm Res, 69, pp.45~52 (2008)
12. Myers SE, "Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits", Am J Med Genet A, 143, pp.443~448 (2007)
13. Butler MG, "Standards for selected anthropometric measurements in Prader-Willi syndrome", Pediatrics, 88, pp.853~860 (1991)
14. Festen DA, "Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome", Clin Endocrinol (Oxf), 69, pp.443~451 (2008)
15. Lin HY, "Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome", J Chin Med Assoc, 71, pp.305~309 (2008)
16. Angulo MA, "Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment", Am J Med Genet A, 143A, pp.1456~1461 (2007)
17. Myers SE, "Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome", J Pediatr, 137, pp.42~49 (2000)
18. Carrel AL, "Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study", J Clin Endocrinol Metab, 87, pp.1581~1585 (2002)
19. Carrel AL, "Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome", J Clin Endocrinol Metab, 95, pp.1131~1136 (2010)
20. Marik PE, "Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine", Crit Care Med, 36, pp.1937~1949 (2008)
21. Eiholzer U, "Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome", J Pediatr, 144, pp.753~758 (2004)
22. Eiholzer U, "Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome?", Eur J Pediatr, 159, pp.299~ (2000)
23. Festen DA, "Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome", Clin Endocrinol (Oxf ), 68, pp.919~925 (2008)
24. Adem A, "Gillberg PG, Nordberg A, Winblad B, et al. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization", Brain Res, 503, pp.299~303 (1989)
25. Redline S, "Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems", Am J Respir Crit Care Med, 159, pp.1527~1532 (1999)
26. Richards A, "The upper airway and sleep apnoea in the Prader- Willi syndrome", Clin Otolaryngol Allied Sci, 19, pp.193~197 (1994)
27. Schluter B, "Respiratory control in children with Prader-Willi syndrome", Eur J Pediatr, 156, pp.65~68 (1997)
28. Holm VA, "Prader-Willi syndrome: consensus diagnostic criteria", Pediatrics, 91, pp.398~402 (1993)
29. Eiholzer U, "Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS", Horm Res, 63, pp.33~39 (2005)
30. Fillion M, "Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome", J Pediatr, 154, pp.230~233 (2009)
31. Nixon GM, "Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome", J Clin Endocrinol Metab, 96, pp.29~33 (2011)
32. Eiholzer U, "Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy", Horm Res, 53, pp.185~192 (2000)
33. Colmenares A, "Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader- Willi syndrome", Horm Res Paediatr, 75, pp.123~130 (2011)
34. Ahl T, "Twenty-four-hour growth hormone profiles in pubertal girls with idiopathic scoliosis", Spine (Phila Pa 1976), 13, pp.139~142 (1988)
35. Skogland LB, "Growth related hormones in idiopathic scoliosis. An endocrine basis for accelerated growth", Acta Orthop Scand, 51, pp.779~780 (1980)
36. Willner S, "Growth hormone and somatomedin A in girls with adolescent idiopathic scoliosis", Acta Paediatr Scand, 65, pp.547~552 (1976)
37. de Lind van Wijngaarden RF, "Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome", J Clin Endocrinol Metab, 94, pp.1274~1280 (2009)
38. Miller JL, "Nutritional phases in Prader-Willi syndrome", Am J Med Genet A, 155A, pp.1040~1049 (2011)
39. Cassidy SB, "Prader-Willi syndrome", Eur J Hum Genet, 17, pp.3~13 (2009)
40. Butler JV, "The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood", Dev Med Child Neurol, 52, pp.e88~e93 (2010)
41. McAllister CJ, "Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding", Int J Obes (Lond), 35, pp.188~197 (2011)
42. Brandau DT, "Autistic and dysmorphic features associated with a submicroscopic 2q33.3-q34 interstitial deletion detected by array comparative genomic hybridization", Am J Med Genet A, 146A, pp.521~524 (2008)
43. Sahoo T, "Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlations", Eur J Hum Genet, 15, pp.943~949 (2007)
44. Santamaria R, "Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America", Clin Genet, 71, pp.273~279 (2007)
45. Schmidt H, "Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up", J Pediatr Endocrinol Metab, 21, pp.651~655 (2008)
46. Vaiani E, "Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life", Clin Endocrinol (Oxf), 73, pp.546~550 (2010)
47. Festen DA, "Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment", Clin Endocrinol (Oxf), 67, pp.449~456 (2007)
48. Bray GA, "The Prader-Willi syndrome: a study of 40 patients and a review of the literature", Medicine (Baltimore), 62, pp.59~80 (1983)
49. Nagai T, "Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment", Am J Med Genet A, 136, pp.45~48 (2005)
50. Grugni G, "The Italian National Survey for Prader-Willi syndrome: an epidemiologic study", Am J Med Genet A, 146, pp.861~872 (2008)
51. Einfeld SL, "Mortality in Prader-Willi syndrome", Am J Ment Retard, 111, pp.193~198 (2006)
52. Tauber M, "Review of 64 cases of death in children with Prader-Willi syndrome (PWS)", Am J Med Genet A, 146, pp.881~887 (2008)
53. Corrias A, "Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome", Clin Endocrinol (Oxf) (2011)
54. Stephenson JB, "Neonatal presentation of Prader-Willi syndrome", Am J Dis Child, 146, pp.151~152 (1992)
55. Hart PS, "Salivary abnormalities in Prader-Willi syndrome", Ann N Y Acad Sci, 842, pp.125~131 (1998)
56. Bailleul-Forestier I, "The oro-dental phenotype in Prader- Willi syndrome: a survey of 15 patients", Int J Paediatr Dent, 18, pp.40~47 (2008)
57. Bazopoulou-Kyrkanidou E, "Prader-Willi syndrome: report of a case with special emphasis on oral problems", J Clin Pediatr Dent, 17, pp.37~40 (1992)
58. Salako NO, "Oral findings in a child with Prader-Labhart-Willi syndrome", Quintessence Int, 26, pp.339~341 (1995)
59. Bots CP, "A patient with Prader-Willi syndrome. Characteristics, oral consequences and treatment options", Ned Tijdschr Tandheelkd, 111, pp.55~58 (2004)
60. Scardina GA, "Oral diseases in a patient affected with Prader-Willi syndrome", Eur J Paediatr Dent, 8, pp.96~99 (2007)
61. Anavi Y, "Prader-Labhart-Willi syndrome", Ann Dent, 49, pp.26~29 (1990)
62. Bassarelli V, "The dentomaxillofacial characteristics of the Prader-Labhart- Willi syndrome. A clinical case report", Minerva Stomatol, 40, pp.811~819 (1991)
63. Banks PA, "Prader-Willi syndrome--a case report of the multidisciplinary management of theorofacial problems", Br J Orthod, 23, pp.299~304 (1996)

관련 논문AI추천